Clinical Trials

The Effect of Ablation Therapy on Barrett's Esophagus

Location:

Rochester, MN

Trial status:

Open for Enrollment

Why is this study being done?

To assess the effect of ablation therapy on Barrett's esophagus. Proposal Ablation therapy is an FDA approved treatment to decrease cancer risk in Barrett's esophagus mucosa. This is being performed in our Barrett's Esophagus Unit on a regular basis. However, the longterm outcomes of this therapy is not established and there are patients who have been treated who later re-develop Barrett's mucosa. This study will allow us store tissue samples that can later be used to assess the effect of ablative therapy on Barrett's esophagus.

Last updated: 05/17/2013

NCT ID:

NCT00587314